{
  "Variants Include": [
    {
      "Gene": "PINK1",
      "variants": [
        {
          "HGVS": "NM_004772.4:c.1298A>G",
          "cDNA Change": {
            "transcript": "NM_004772.4",
            "ref": "A",
            "alt": "G",
            "position": "1298"
          },
          "Protein Change": {
            "ref": "N",
            "alt": "A",
            "position": "433"
          },
          "Description in input context": "c.1298A>G (p.N433A)"
        }
      ]
    }
  ],
  "Described Disease": {
    "Described Disease": "Parkinsonâ€™s disease",
    "MONDO": "MONDO:0003354"
  },
  "Experiment Method": [
    {
      "Assay Method": "Western Blot",
      "Material used": {
        "Material Source": "Patients Derived Material",
        "Material Name": "Patient-derived fibroblasts",
        "Description": "The experiment was conducted using patient-derived fibroblasts."
      },
      "Readout type": "Quantitative",
      "Readout description": [
        {
          "Variant": "NM_004772.4:c.1298A>G",
          "Conclusion": "Abnormal",
          "Molecular Effect": "partial loss-of-function",
          "Result Description": "Western blot analysis showed a reduced level of Parkin protein in fibroblasts carrying the c.1298A>G variant compared to control fibroblasts (approximately 60% reduction)."
        }
      ],
      "Biological replicates": {
        "Biological replicates": "Yes",
        "Description": "Three independent experiments were performed for each condition."
      },
      "Technical replicates": {
        "Technical replicates": "Yes",
        "Description": "Three technical replicates were run for each sample."
      },
      "Basic positive control": {
        "Basic positive control": "Yes",
        "Description": "Wild-type PINK1 cDNA was introduced as a positive control."
      },
      "Basic negative control": {
        "Basic negative control": "N/A",
        "Description": "Not mentioned in the text"
      },
      "Validation controls P/LP": {
        "Validation controls P/LP": "N/A",
        "Counts": "N/A"
      },
      "Validation controls B/LB": {
        "Validation controls B/LB": "N/A",
        "Counts": "N/A"
      },
      "Statistical analysis method": {
        "Statistical analysis method": "N/A"
      },
      "Threshold for normal readout": {
        "Threshold for normal readout": "Protein expression level comparable to control fibroblasts. (Inferred)",
        "Source": "Inferred"
      },
      "Threshold for abnormal readout": {
        "Threshold for abnormal readout": "Protein expression level significantly below control fibroblasts (60% reduction indicated).",
        "Source": "Literature"
      },
      "Approved assay": {
        "Approved assay": "Yes"
      }
    }
  ]
}